Prognostic potential of serum CA 125 levels in danazol-treated patients with external endometriosis: a preliminary study

Int J Fertil. 1990 Jul-Aug;35(4):226-9.

Abstract

Serum levels of CA 125 in 33 patients with progressive external endometriosis who were treated with 400 mg/day of Danazol for 16 weeks were assayed for an extended period (24-40 weeks), and changes in the CA 125 pattern were analyzed. Patterns of hormonal response were classified into four types. Prognosis for one type was good, whereas that for the other three types was poor. By making use of these patterns, we were able to determine more accurately the proper dose of Danazol, to alter the duration of treatment, and to predict relapse.

MeSH terms

  • Adult
  • Antigens, Tumor-Associated, Carbohydrate / blood*
  • Danazol / administration & dosage
  • Danazol / therapeutic use*
  • Endometriosis / blood*
  • Endometriosis / drug therapy
  • Endometriosis / epidemiology
  • Female
  • Humans
  • Japan / epidemiology
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Predictive Value of Tests
  • Prognosis
  • Uterine Neoplasms / blood*
  • Uterine Neoplasms / drug therapy
  • Uterine Neoplasms / epidemiology

Substances

  • Antigens, Tumor-Associated, Carbohydrate
  • Danazol